Endoscopic rubber band ligation, injection sclerotherapy, and sclerobanding for the treatment of internal hemorrhoids

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 5

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Feb 7, 2026; 32(5): 116007
Published online Feb 7, 2026. doi: 10.3748/wjg.v32.i5.116007

Table 2 Treatment data

Subgroup	Rubber bands [number, median (Q1, Q3)]	Sclerosant dosage [mL, median (Q1, Q3)]	Anesthesia method (local/intravenous anesthesia)	Follow-up duration [months, median (Q1, Q3)]
ERBL	4.00 (3.00, 5.00)		42/28	20.50 (9.00, 24.00)
IS		9.5 (6.75, 10.00)	42/24	23.50 (13.00, 24.00)
ESB	4.00 (3.00, 5.00)	8.00 (6.00, 10.00)	45/20	18.00 (11.25, 24.00)
Total	4.00 (3.00, 5.00)	8.00 (6.00, 10.00)	129/72	20.00 (12.00, 24.00)
Statistic	Z = -0.901	Z = -1.496	χ² = 1.262	H = 0.909
P value	0.367	0.135	0.532	0.635

ERBL: Endoscopic rubber band ligation; IS: Injection sclerotherapy; ESB: Endoscopic polidocanol sclerobanding.

Citation: Zu N, Jing X, Zhou XY, Ma BB, Wang SJ, Qi XS, Liu LB. Endoscopic rubber band ligation, injection sclerotherapy, and sclerobanding for the treatment of internal hemorrhoids. World J Gastroenterol 2026; 32(5): 116007
URL: https://www.wjgnet.com/1007-9327/full/v32/i5/116007.htm
DOI: https://dx.doi.org/10.3748/wjg.v32.i5.116007

Zu N, Jing X, Zhou XY, Ma BB, Wang SJ, Qi XS, Liu LB. Endoscopic rubber band ligation, injection sclerotherapy, and sclerobanding for the treatment of internal hemorrhoids. World J Gastroenterol 2026; 32(5): 116007 [PMID: 41693967 DOI: 10.3748/wjg.v32.i5.116007]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.